Read Larry Connors' blog – Short Term Trading Strategies
1. All implants were easily implanted. 2. No titanium particle debris was observed after implant retrieval, suggesting that the titanium foam has sufficient abrasion resistance, at least for the conditions used in this study. 3. The initial stability of all implants was good. However, the torque required to unscrew the implants was slightly larger for the implants without foam. This finding was associated with the enlargement of the holes caused by the abrasion of the bone by the foam. A modification of the design was proposed to address this issue and increase the contact area between the implant and the crestal bone. 4. Important amount of bone interlocked in the foam was observed after implantation. It is believed that this will provide good implant stability after bone remodeling. 5. The fatigue limits of the implants with and without foam were similar. This is a positive finding considering the results reported in the literature on the effect of porous coating on the fatigue of Ti6Al4V implants.
The full report will be posted on our website www.opencellbiomed.com.
OpenCell BioMed Inc. is a medical device designer and manufacturer specializing in innovative designs merging proprietary biomedical materials with human cell biology. The company is developing a unique line of dental implants and related products for sale worldwide. OpenCell BioMed is differentiated by its proprietary paradigm shift surface coating/material TI FOAM(TM). Used as the bone to implant interface enabling dental implant systems, it has greater short and long term stability with minimally invasive techniques compared to traditional dental implant systems.
"The completion of phase-2 brings us another step closer to the completion of our research and development project with the CNRC and subsequent commercialization of the TI FOAM(TM) dental implant line." (Dr. Mislav Pavelic, CEO-OpenCell BioMed Inc.)
About OpenCell BioMed Inc.
OpenCell BioMed is a medical device designer and manufacturer specializing in innovative designs merging proprietary biomedical materials with human cell biology. The company is developing a unique line of dental implants and related products for sale worldwide.
About Dental Implants
Dental implants are designed as permanent replacements for missing teeth. A dental implant is a metal post that is surgically placed into the bone under the gums. The purpose of the placement into the bone is to encourage the integration of the dental implants. The bone actually grows around the dental implant, making the tooth secure. A replacement tooth is attached to the titanium post by means of a final abutment. Did you know that dental implants are frequently the best treatment option for replacing missing teeth? Rather than resting on the gum line like removable dentures, or using adjacent teeth as anchors like fixed bridges, dental implants are long-term replacements.
Cautionary Statement Regarding Forward-Looking Information: Except for statements of historical fact relating to the Corporation, certain information contained herein constitutes forward-looking statements. Forward-looking statements are frequently characterized by words such as "potential," "estimate," "plan," "expect," "project," "intend," "believe," "anticipate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change. The reader is cautioned not to place undue reliance on forward-looking statements.
For further information, contact: Karen Willoughby Corporate Relations Group Phone: 1-888-323-0929 Website: www.opencellbiomed.com E-mail: Email Contact
SOURCE: OpenCell BioMed Inc.
http://www.opencellbiomed.com http://www2.marketwire.com/mw/emailprcntct?id=873C8AEC3B2F9D54
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
